|
 Roll back malaria and other
mosquito-borne diseases:
 Providing technical support to
the Ministry of Health for prevention and control of malaria and other
mosquito-borne diseases:
development of policies,
strategies and guidelines;
training;
planning, implementation,
monitoring and evaluation;
development of information,
education and communication strategy and materials;
 conduct research.
Advocacy and resource
mobilization.
Coordination with partners and
dissemination of technical information.
Supporting Ministry of Health
and other partners in addressing major issues on malaria control such as
multi-drug resistance, fake/counterfeit drugs, malaria among migrant workers
and ethnic groups, quality assurance of drugs and diagnostics.
Facilitating cross-border
collaboration.
Facilitating human resource
development through local and international training.
Supporting morbidity control and
mass drug administration for elimination of lymphatic filariasis.
 Providing logistics support
|
Experts Recommend Actions to Prevent the Emergence
and Spread of Anti-malarial Drugs Resistance in Myanmar
|
|
The Department of Medical Research (Lower Myanmar), in
collaboration with WHO, successfully concluded a Technical Meeting on
Anti-malarial Drug Resistance in Myanmar on 13 March 2009. Experts on
malaria from national and international organizations and representatives
from Food and Drug Administration and the pharmaceutical companies in Myanmar
participated. They concluded that treatment failure rates to artemisinin-based combination treatments (ACTs) is high, and the prolonged parasite clearance
time documented in seven cases is a concern. However, it was not clear if
the treatment failures and the prolonged parasite clearance time were due
to Plasmodium falciparum resistance to artemisinins since pharmacokinetic studies were not
done and Polymerase Chain Reaction (PCR) analysis was only done for studies
carried out in 2007. Previous
report on two cases of P. vivax malaria resistant
to chloroquine was noted. Further studies are needed to validate
resistance of P. vivax to chloroquine
and to determine the magnitude.
More Information
|
|
|
|
Improving Quality of Management of Malaria by the
Private General Practitioners
|
|
The case management of malaria by the general
practitioners (GPs) is being improved through Quality Diagnosis and
Standard Treatment of Malaria Project.
It is being implemented by Myanmar Medical Association (MMA) with
financial grant from Three Diseases Fund
and with technical and management support by WHO. In addition, the WHO Mekong Malaria Programme provides support to MMA to promote to GPs nationwide
the rational use of recommended antimalarial
drugs as per national malaria treatment policy.
More Information
|
|
MCC-WHO-3DF community-based malaria control: progress
and challenges
|
|
|
Empowered village health volunteers are making
significant contributions towards malaria control, there is no more death
attributed to malaria in their respective communities and the villagers
appreciated very much their services. These sum up the progress to date of
community-based malaria control project in 160 remote hard to reach
villages being implemented by the Myanmar Council of Churches (MCC). It is
financially supported by Three Diseases Fund (3DF), and with technical and
management support by WHO.
More Information
|
|
